Der Sheng Sun

764 total citations
40 papers, 570 citations indexed

About

Der Sheng Sun is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Der Sheng Sun has authored 40 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 14 papers in Cancer Research and 9 papers in Molecular Biology. Recurrent topics in Der Sheng Sun's work include MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (5 papers) and Lung Cancer Research Studies (5 papers). Der Sheng Sun is often cited by papers focused on MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (5 papers) and Lung Cancer Research Studies (5 papers). Der Sheng Sun collaborates with scholars based in South Korea and United States. Der Sheng Sun's co-authors include Yoon Ho Ko, Hye Sung Won, Ji Hyung Hong, Jungsoo Lee, Soon Auck Hong, Ho Jung An, Byoung Yong Shim, Hyeon Woo Yim, H. Lee and Young‐Ho Ahn and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Der Sheng Sun

37 papers receiving 561 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Der Sheng Sun South Korea	15	228	226	150	120	79	40	570
Xiaolin Zhu China	13	219 1.0×	151 0.7×	110 0.7×	104 0.9×	47 0.6×	35	564
John R. Barber United States	15	169 0.7×	174 0.8×	142 0.9×	220 1.8×	100 1.3×	40	652
Jiannan Yao China	14	188 0.8×	237 1.0×	106 0.7×	84 0.7×	85 1.1×	45	553
Helen Yang United States	12	187 0.8×	171 0.8×	78 0.5×	80 0.7×	41 0.5×	27	520
Erdem Çubukçu Türkiye	12	106 0.5×	253 1.1×	103 0.7×	75 0.6×	34 0.4×	51	481
Annie Tan United States	10	339 1.5×	182 0.8×	88 0.6×	84 0.7×	50 0.6×	18	724
Massimiliano Salati Italy	12	197 0.9×	394 1.7×	170 1.1×	186 1.6×	71 0.9×	25	743
Masayo Tsukamoto Japan	13	150 0.7×	297 1.3×	112 0.7×	115 1.0×	100 1.3×	36	612
Leung Li Hong Kong	14	132 0.6×	209 0.9×	98 0.7×	104 0.9×	38 0.5×	33	571
Anita Chudecka-Głaz Poland	17	227 1.0×	232 1.0×	155 1.0×	51 0.4×	96 1.2×	85	863

Countries citing papers authored by Der Sheng Sun

Since Specialization

Citations

This map shows the geographic impact of Der Sheng Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Der Sheng Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Der Sheng Sun more than expected).

Fields of papers citing papers by Der Sheng Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Der Sheng Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Der Sheng Sun. The network helps show where Der Sheng Sun may publish in the future.

Co-authorship network of co-authors of Der Sheng Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Der Sheng Sun. A scholar is included among the top collaborators of Der Sheng Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Der Sheng Sun. Der Sheng Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Won, Hye Sung, et al.. (2025). Spatial gene expression profiling identifies prognostic features of residual tumors after neoadjuvant chemotherapy in triple-negative breast cancer. Frontiers in Oncology. 15. 1638758–1638758. 1 indexed citations

Lim, Seung Taek, Hye Ryun Kim, Eun Joo Kang, et al.. (2024). Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma: Post hoc analysis of TRIUMPH study. Oral Oncology. 151. 106739–106739. 2 indexed citations

Kim, Hyunho, Hyung Soon Park, Ho Jung An, et al.. (2023). A Randomized Phase III Study of Patients With Advanced Gastric Adenocarcinoma Without Progression After Six Cycles of XELOX (Capecitabine Plus Oxaliplatin) Followed by Capecitabine Maintenance or Clinical Observation. Journal of the Korean Gastric Cancer Association. 23(2). 315–315. 2 indexed citations

Lee, Dong Soo, et al.. (2023). Association between Posttreatment Serum Platelet-to-Lymphocyte Ratio and Distant Metastases in Patients with Hepatocellular Carcinoma Receiving Curative Radiation Therapy. Cancers. 15(7). 1978–1978. 2 indexed citations

Won, Hye Sung, Ji Hyun Yang, Der Sheng Sun, et al.. (2022). Prognostic value of Dickkopf-1 and ß-catenin expression according to the antitumor immunity of CD8-positive tumor-infiltrating lymphocytes in biliary tract cancer. Scientific Reports. 12(1). 1931–1931. 4 indexed citations

Sun, Der Sheng, Yoon Ho Ko, Jong‐Youl Jin, et al.. (2022). Efficacy of the granisetron transdermal system for the control of nausea and vomiting induced by highly emetogenic chemotherapy: a multicenter, randomized, controlled trial. The Korean Journal of Internal Medicine. 38(3). 406–416. 2 indexed citations

Chun, Sang Hoon, Eun Young Kim, Hye Sung Won, et al.. (2021). Prognostic value of noggin protein expression in patients with resected gastric cancer. BMC Cancer. 21(1). 558–558. 7 indexed citations

Park, Hyung Soon, Hye Sung Won, Ho Jung An, et al.. (2020). Elevated serum substance P level as a predictive marker for moderately emetogenic chemotherapy‐induced nausea and vomiting: A prospective cohort study. Cancer Medicine. 10(3). 1057–1065. 10 indexed citations

Kim, Yong‐Seok, et al.. (2020). Clinical implications of APOBEC3A and 3B expression in patients with breast cancer. PLoS ONE. 15(3). e0230261–e0230261. 12 indexed citations

10.

Sun, Der Sheng, Hye Sung Won, Soon Auck Hong, et al.. (2019). Prognostic implications of stromal hyaluronic acid protein expression in resected oropharyngeal and oral cavity cancers. The Korean Journal of Internal Medicine. 35(2). 408–420. 6 indexed citations

11.

Lee, Jungsoo, Ji Hyung Hong, Der Sheng Sun, et al.. (2019). The impact of systemic treatment on brain metastasis in patients with non-small-cell lung cancer: A retrospective nationwide population-based cohort study. Scientific Reports. 9(1). 18689–18689. 24 indexed citations

12.

Kim, Se Hyun, Jin Won Kim, In Gyu Hwang, et al.. (2019). Serum biomarkers for predicting overall survival and early mortality in older patients with metastatic solid tumors. Journal of Geriatric Oncology. 10(5). 749–756. 15 indexed citations

13.

Won, Hye Sung, et al.. (2018). Factors associated with treatment interruption in elderly patients with cancer. The Korean Journal of Internal Medicine. 34(1). 156–164. 9 indexed citations

14.

An, Ho Jung, Heejoon Jo, Chan Kwon Jung, et al.. (2017). Prognostic implication of ERCC1 protein expression in resected oropharynx and oral cavity cancer. Pathology - Research and Practice. 213(8). 949–955. 6 indexed citations

15.

Sun, Der Sheng, H. Lee, Hyeon Woo Yim, Hye Sung Won, & Yoon Ho Ko. (2017). The impact of sarcopenia on health-related quality of life in elderly people: Korean NationalHealth and Nutrition Examination Survey. The Korean Journal of Internal Medicine. 34(4). 877–884. 53 indexed citations

16.

Seo, Kyung Jin, Jiyeon Hyeon, Ok Ran Shin, et al.. (2017). Gastroenteropancreatic—origin neuroendocrine carcinomas. Medicine. 96(49). e9009–e9009. 2 indexed citations

17.

Shim, Byoung Yong, Der Sheng Sun, Hye Sung Won, et al.. (2016). Role of autophagy-related protein expression in patients with rectal cancer treated with neoadjuvant chemoradiotherapy. BMC Cancer. 16(1). 207–207. 14 indexed citations

18.

Sun, Der Sheng, Eun Kyoung Jeon, Hye Sung Won, et al.. (2014). Outcomes in elderly patients treated with a single-agent or combination regimen as first-line chemotherapy for recurrent or metastatic gastric cancer. Gastric Cancer. 18(3). 644–652. 16 indexed citations

19.

Shim, Byoung Yong, Ji‐Han Jung, Kang‐Moon Lee, et al.. (2012). Glucose transporter 1 (GLUT1) of anaerobic glycolysis as predictive and prognostic values in neoadjuvant chemoradiotherapy and laparoscopic surgery for locally advanced rectal cancer. International Journal of Colorectal Disease. 28(3). 375–383. 38 indexed citations

20.

Rhee, Chin Kook, Sang Haak Lee, Ju Sang Kim, et al.. (2010). A multicenter phase II study of belotecan, a new camptothecin analogue, as a second-line therapy in patients with small cell lung cancer. Lung Cancer. 72(1). 64–67. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact